Scholarlink

Background <p>Tonsillectomy is a common surgical procedure for recurrent tonsillitis and obstructive sleep apnea. Its effects on quality-of-life outcomes using validated instruments remain limited. This study aimed to evaluate the impact of tonsillectomy on health-related quality of life over 12 months using disease-specific and generic outcome measures.</p> Methods <p>This is a prospective cohort study involving 103 adult patients (aged 18–50 years) undergoing elective tonsillectomy. Participants completed the Tonsil and Adenoid Health Status Instrument (TAHSI) and Short Form-12 (SF-12) Health Survey at baseline, 6 months, and 12 months post-operatively. Primary indications included recurrent infection (84.5%), sleep apnea (3.9%), and tonsillar stones (11.7%). Repeated measures ANOVA assessed temporal changes, effect sizes were calculated using Cohen’s d, and multiple regression identified outcome predictors.</p> Results <p>Study participants comprised 53 males (51.5%) and 50 females (48.5%) with a mean age of 30.41 ± 7.63 years. TAHSI scores improved significantly from baseline (46.8) to 6 months (8.9; 80.8% improvement) and 12 months (11.2; 76.1% improvement). All domains showed substantial improvements, with infection symptoms demonstrating the greatest effect (Cohen’s d = 2.01). Clinical significance was achieved by 91.6% of patients for throat infections and 84.2% for overall quality of life. SF-12 Mental Component Scores increased from 47.82 to 54.91, while Physical Component Scores improved from 46.15 to 53.27 at 12 months. Baseline symptom severity predicted outcomes, while age showed no significant association.</p> Conclusion <p>Tonsillectomy produces substantial, sustained improvements in disease-specific symptoms and general quality-of-life measures in adult patients, with benefits maintained over 12 months across multiple health domains.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Health-related quality of life and functional recovery outcomes following tonsillectomy among patients in Hail, Saudi Arabia

  • 期刊论文

  • 发表日期：

    2026年3月30日

查看全文
  • Abdullah D. Alotaibi,
  • Mubashir Zafar,
  • Fahad N. Alshammari,
  • Abdulrahman Fahad Alrashdi,
  • Khalid Samit Alreshidi,
  • Faisal Fawaz Alshammari,
  • Osama Obaid Alharbi,
  • Omar Mohammed Alassaf,
  • Fahad Maiyah Alshammari,
  • Meshary Mohammad Altwalh,
  • Mohammed Fahad alateeq,
  • Abdulaziz S. AlQahtani

摘要

Background

Tonsillectomy is a common surgical procedure for recurrent tonsillitis and obstructive sleep apnea. Its effects on quality-of-life outcomes using validated instruments remain limited. This study aimed to evaluate the impact of tonsillectomy on health-related quality of life over 12 months using disease-specific and generic outcome measures.

Methods

This is a prospective cohort study involving 103 adult patients (aged 18–50 years) undergoing elective tonsillectomy. Participants completed the Tonsil and Adenoid Health Status Instrument (TAHSI) and Short Form-12 (SF-12) Health Survey at baseline, 6 months, and 12 months post-operatively. Primary indications included recurrent infection (84.5%), sleep apnea (3.9%), and tonsillar stones (11.7%). Repeated measures ANOVA assessed temporal changes, effect sizes were calculated using Cohen’s d, and multiple regression identified outcome predictors.

Results

Study participants comprised 53 males (51.5%) and 50 females (48.5%) with a mean age of 30.41 ± 7.63 years. TAHSI scores improved significantly from baseline (46.8) to 6 months (8.9; 80.8% improvement) and 12 months (11.2; 76.1% improvement). All domains showed substantial improvements, with infection symptoms demonstrating the greatest effect (Cohen’s d = 2.01). Clinical significance was achieved by 91.6% of patients for throat infections and 84.2% for overall quality of life. SF-12 Mental Component Scores increased from 47.82 to 54.91, while Physical Component Scores improved from 46.15 to 53.27 at 12 months. Baseline symptom severity predicted outcomes, while age showed no significant association.

Conclusion

Tonsillectomy produces substantial, sustained improvements in disease-specific symptoms and general quality-of-life measures in adult patients, with benefits maintained over 12 months across multiple health domains.